Takeda R&D Exec Explains How $1.2B Deal Could Become One of the Biggest Bargains in Drug History

Bispecific antibodies are one of the hottest areas for drug research and dealmaking, and several of them were discussed this week during the annual J.P. Morgan Healthcare Conference in San Francisco. Takeda President, Research and Development, Andy Plump talked to MedCity News about what sets the Japanese pharma company’s newly licensed drug apart. The post…

Read More

MedCity FemFwd: Designing Healthcare Spaces for Women

In this episode, we’re joined by Abbie Clary, executive director of Health for All for CannonDesign, an architecture design company. She discusses why healthcare traditionally hasn’t been built around women, and what needs to change. The post MedCity FemFwd: Designing Healthcare Spaces for Women appeared first on MedCity News.

Read More